DUX4 and facioscapulohumeral muscular dystrophy: The low mosaic expression of DUX4 in this mouse model leads to many aspects of FSHD pathophysiology in skeletal muscle, including increased centrally nucleated myofibers, immune cell infiltration, and reduced muscle regeneration [13, 14, 26, 27, 32–34].